scholarly journals Local outbreak of Streptococcus pneumoniae serotype 12F caused high morbidity and mortality among children and adults

2018 ◽  
Vol 146 (14) ◽  
pp. 1793-1796 ◽  
Author(s):  
T. Ikuse ◽  
R. Habuka ◽  
Y. Wakamatsu ◽  
T. Nakajima ◽  
N. Saitoh ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Continuous Monitoring ◽  
Close Contact ◽  
Control Strategies ◽  
High Morbidity ◽  
Transmission Route ◽  
Pneumococcal Serotypes ◽  
Serotype Replacement ◽  
Pneumococcal Serotype

AbstractPneumococcal serotype replacement is an important issue after the introduction of pneumococcal conjugate vaccine (PCV) in children. After the introduction of 13-valent PCV, the incidence of invasive pneumococcal diseases (IPD) caused by Streptococcus pneumoniae serotype 12F (Sp12F) have increased in some countries; however, an outbreak of Sp12F has not reported in the post-13-valent PCV era. We experienced a local outbreak of Sp12F during March through May 2016 in Tsuruoka city, Japan after the introduction of 13-valent PCV in 2013. The IPD patients were two children and seven adults, three of whom died with a rapid disease progress. Although the clear transmission route was not determined, eight of the nine patients (89%) had close contact with children, which suggests that transmitted colonisation of Sp12F among children and adults might be the source of transmission. Continuous monitoring of IPDs, along with the determination of pneumococcal serotypes, is warranted in the post–13-valent PCV era. New IPD control strategies may be needed if this fatal outbreak continues to occur.

scholarly journals Genetic Relatedness of the Streptococcus pneumoniae Capsular Biosynthetic Loci

2007 ◽  
Vol 189 (21) ◽  
pp. 7841-7855 ◽  
Author(s):  
Angeliki Mavroidi ◽  
David M. Aanensen ◽  
Daniel Godoy ◽  
Ian C. Skovsted ◽  
Margit S. Kaltoft ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Genetic Relatedness ◽  
Pneumococcal Serotypes ◽  
Major Cluster ◽  
Genes Encoding ◽  
Pneumococcal Serotype ◽  
Streptococcal Polysaccharide ◽  
Single Cluster ◽  
Dependent Pathway ◽  
Sequence Similarities

ABSTRACT Streptococcus pneumoniae (the pneumococcus) produces 1 of 91 capsular polysaccharides (CPS) that define the serotype. The cps loci of 88 pneumococcal serotypes whose CPS is synthesized by the Wzy-dependent pathway were compared with each other and with additional streptococcal polysaccharide biosynthetic loci and were clustered according to the proportion of shared homology groups (HGs), weighted for the sequence similarities between the genes encoding the shared HGs. The cps loci of the 88 pneumococcal serotypes were distributed into eight major clusters and 21 subclusters. All serotypes within the same serogroup fell into the same major cluster, but in six cases, serotypes within the same serogroup were in different subclusters and, conversely, nine subclusters included completely different serotypes. The closely related cps loci within a subcluster were compared to the known CPS structures to relate gene content to structure. The Streptococcus oralis and Streptococcus mitis polysaccharide biosynthetic loci clustered within the pneumococcal cps loci and were in a subcluster that also included the cps locus of pneumococcal serotype 21, whereas the Streptococcus agalactiae cps loci formed a single cluster that was not closely related to any of the pneumococcal cps clusters.

scholarly journals Evaluating post-vaccine expansion patterns of pneumococcal serotypes

2020 ◽  
Author(s):  
Maile T. Phillips ◽  
Joshua L. Warren ◽  
Noga Givon-Lavi ◽  
Adrienn Tothpal ◽  
Gili Regev-Yochay ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Invasive Pneumococcal Disease ◽  
Jewish Population ◽  
Pneumococcal Disease ◽  
Pneumococcal Serotypes ◽  
Conjugate Vaccines ◽  
Pneumococcal Conjugate Vaccines ◽  
Vaccine Serotypes ◽  
Serotype Replacement ◽  
Disease Understanding

ABSTRACTStreptococcus pneumoniae remains a leading cause of morbidity and mortality. Pneumococcal conjugate vaccines (PCVs) are effective but target only a fraction of the more than 90 pneumococcal serotypes. As a result, the introduction of PCVs has been followed by the emergence of non-vaccine serotypes. With higher-valency PCVs currently under development, there is a need to understand and predict patterns of serotype replacement to anticipate future changes. In this study, we evaluated patterns of change in serotype prevalence post-PCV introduction in Israel. We found that the assumption that non-vaccine serotypes increase by the same proportion overestimates changes in serotype prevalence in Jewish and Bedouin children. Furthermore, pre-vaccine prevalence was positively associated with increases in prevalence over the study period. From our analyses, serotypes 12F, 8, 16F, 33F, 9N, 7B, 10A, 22F, 24F, and 17F were estimated to have gained the most cases of invasive pneumococcal disease through serotype replacement in the Jewish population. However, this model also failed to quantify some additional cases gained, suggesting that changes in carriage in children alone may be insufficient to explain serotype replacement in disease. Understanding of serotype replacement is important as higher-valency vaccines are introduced.

scholarly journals Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project

2021 ◽  
Vol 9 (4) ◽  
pp. 696 ◽  
Author(s):  
Julia Bennett ◽  
Marissa Hetrich ◽  
Maria Garcia Quesada ◽  
Jenna Sinkevitch ◽  
Maria Deloria Knoll ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Incidence Rate ◽  
Invasive Pneumococcal Disease ◽  
Pneumococcal Disease ◽  
Mixed Effects ◽  
Data Availability ◽  
Serotype Replacement ◽  
Serotype 1 ◽  
Pneumococcal Serotype ◽  
Rate Ratios

Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (PCVs) containing ST1 antigen. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project gathered ST1 IPD surveillance data from sites globally and aimed to estimate PCV10/13 impact on ST1 IPD incidence. We estimated ST1 IPD incidence rate ratios (IRRs) comparing the pre-PCV10/13 period to each post-PCV10/13 year by site using a Bayesian multi-level, mixed-effects Poisson regression and all-site IRRs using a linear mixed-effects regression (N = 45 sites). Following PCV10/13 introduction, the incidence rate (IR) of ST1 IPD declined among all ages. After six years of PCV10/13 use, the all-site IRR was 0.05 (95% credibility interval 0.04–0.06) for all ages, 0.05 (0.04–0.05) for <5 years of age, 0.08 (0.06–0.09) for 5–17 years, 0.06 (0.05–0.08) for 18–49 years, 0.06 (0.05–0.07) for 50–64 years, and 0.05 (0.04–0.06) for ≥65 years. PCV10/13 use in infant immunization programs was followed by a 95% reduction in ST1 IPD in all ages after approximately 6 years. Limited data availability from the highest ST1 disease burden countries using a 3 + 0 schedule constrains generalizability and data from these settings are needed.

scholarly journals Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination

2021 ◽  
Vol 6 (4) ◽  
pp. 54-66
Author(s):  
I. N. Protasova ◽  
S. V. Sidorenko ◽  
I. V. Feldblum ◽  
N. V. Bakhareva
Keyword(s):  
Streptococcus Pneumoniae ◽  
Age Groups ◽  
Pneumococcal Vaccination ◽  
Healthy Children ◽  
Pneumococcal Serotypes ◽  
Older Children ◽  
Pneumococcal Carriage ◽  
Serotype Replacement ◽  
High Prevalence ◽  
Before And After

Aim. To investigate how the pneumococcal vaccination affects the distribution of Streptococcus pneumoniae serotypes.Materials and Methods. In 2011-2019, 1,852 healthy children (1,354 aged ≤ 5 years and 480 aged from 6 to 17 years) were examined for the nasopharyngeal pneumococcal carriage. Of them, 539 children were tested before the start of pneumococcal vaccination (2011-2014), while 1,313 were tested during the vaccine campaign (2015-2019). Pneumococcal strains were serotyped using multiplex polymerase chain reaction.Results. Streptococcus pneumoniae serotype distribution considerably differed between children ≤ 5 and 6-17 years of age. Serotypes 23F, 19F, 19A, 6AB, and 15BC were prevalent in children ≤ 5 years of age while the older children were characterised by a high prevalence of capsular serotypes (3 and 33AF/37), serogroup 9 (9AV and 9LN), non-typeable streptococci, as well as 19F, 6AB and 6CD serotypes. Vaccination was associated with a significantly decreased prevalence of Streptococcus pneumoniae carriage (from 41.5% to 19.2%) among children ≤ 5 years of age, while this reduction was less pronounced (from 13.5 to 9.0%) in older children. Vaccination led to the shift in the distribution of pneumococcal serotypes towards an increased prevalence of non-vaccine serotypes that was particularly prominent in children ≤ 5 years of age. In particular, vaccination reduced the prevalence of 23F and 19A pneumococcal serotypes but heightened prevalence of 11AD serotype and to the appearance of previously undetected serotypes such as 8, 10A, 17F, 22F, 24ABF, 34, and 39.Conclusion. Pneumococcal vaccination decreased prevalence of pneumococcal carriage, yet causing a serotype replacement effect requiring improved microbiological monitoring in children of all age groups.

scholarly journals Serotype Distribution and Antimicrobial Resistance ofStreptococcus pneumoniaeIsolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014

2016 ◽  
Vol 2016 ◽  
pp. 1-7
Author(s):  
Si Hyun Kim ◽  
Il Kwon Bae ◽  
Dongchul Park ◽  
Kyungmin Lee ◽  
Na Young Kim ◽  
...  
Keyword(s):  
Antimicrobial Susceptibility ◽  
Vaccine Coverage ◽  
Multidrug Resistant ◽  
Resistance Rate ◽  
High Morbidity ◽  
Pneumococcal Serotypes ◽  
Serotype Distribution ◽  
Pneumococcal Serotype ◽  
Common Serotypes ◽  
Coverage Rates

Introduction.Streptococcus pneumoniaeis an important pathogen with high morbidity and mortality rates. The aim of this study was to evaluate the distribution of common serotypes and antimicrobial susceptibility ofS. pneumoniaein Korea.Methods. A total of 378 pneumococcal isolates were collected from 2008 through 2014. We analyzed the serotype and antimicrobial susceptibility for both invasive and noninvasive isolates.Results. Over the 7 years, 3 (13.5%), 35 (10.8%), 19A (9.0%), 19F (6.6%), 6A (6.1%), and 34 (5.6%) were common serotypes/serogroups. The vaccine coverage rates of PCV7, PCV10, PCV13, and PPSV23 were 21.4%, 23.3%, 51.9%, and 62.4% in all periods. The proportions of serotypes 19A and 19F decreased and nonvaccine serotypes increased between 2008 and 2010 and 2011 and 2014. Of 378S. pneumoniaeisolates, 131 (34.7%) were multidrug resistant (MDR) and serotypes 19A and 19F were predominant. The resistance rate to levofloxacin was significantly increased (7.2%).Conclusion. We found changes of pneumococcal serotype and antimicrobial susceptibility during the 7 years after introduction of the first pneumococcal vaccine. It is important to continuously monitor pneumococcal serotypes and their susceptibilities.

scholarly journals Subcutaneous abscess caused by Streptococcus pneumoniae serotype 28F in an infant: a case report

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Tomohiro Hirade ◽  
Ai Harada ◽  
Daisuke Koike ◽  
Yasuhiro Abe ◽  
Tsuyoshi Higuchi ◽  
...  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Incision And Drainage ◽  
Case Presentation ◽  
Vaccine Serotypes ◽  
Global Issue ◽  
Serotype Replacement ◽  
Pneumococcal Serotype ◽  
Sterile Site ◽  
International Data ◽  
Highly Virulent

Abstract Background Invasive pneumococcal disease (IPD) is defined by the detection of Streptococcus pneumoniae on culture from samples obtained from a normally sterile site. Pneumococcal conjugate vaccines (PCV) have been developed for the prevention of IPD that is caused by highly virulent serotypes. Despite the effective reduction of IPD caused by vaccine serotypes after the introduction of PCV, there has been a rapid increase in the incidence of IPD caused by non-vaccine serotypes, and serotype replacement has become a global issue. Case presentation We report a previously healthy 4-month-old girl presenting with a large subcutaneous abscess caused by S. pneumoniae, identified as non-vaccine serotype 28F. The patient had received routine vaccination, including PCV vaccination. After the incision and drainage of the subcutaneous abscess, the patient was treated with antibiotics. She was discharged on Day 7 of hospitalization without any residual sequelae. Conclusions Subcutaneous abscess is a common pediatric skin and soft tissue infection, whereas pneumococcal subcutaneous abscesses are quite rare. As the pneumococcal serotype 28F caused a subcutaneous abscess, this serotype possibly has a high virulence. The incidence of IPD caused by non-vaccine serotypes, such as 28F, is expected to increase in the future. The consolidation of international data on pneumococcal serotypes is important for the development of novel PCV.

scholarly journals Easing or tightening control strategies: determination of COVID-19 parameters for an agent-based model

2021 ◽  
Author(s):  
Ali Najmi ◽  
Sahar Nazari ◽  
Farshid Safarighouzhdi ◽  
Eric J. Miller ◽  
Raina MacIntyre ◽  
...  
Keyword(s):  
Control Strategies ◽  
Agent Based Model ◽  
Agent Based

scholarly journals Determination of the frequency of carbapenemase producing Klebsiella pneumoniae isolates in Dhaka city, Bangladesh

2013 ◽  
Vol 2 (1) ◽  
pp. 28-30 ◽  
Author(s):  
Nawshad Hayder ◽  
Zahidul Hasan ◽  
Sadia Afrin ◽  
Rashed Noor
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Klebsiella Pneumoniae ◽  
Respiratory Diseases ◽  
High Morbidity ◽  
Wound Infections ◽  
Dhaka City ◽  
Carbapenem Resistant ◽  
Global Health Problem

Resistance of Klebsiella pneumoniae against carbapenem, imparted by the presence of carbapenemase, is an emerging global health problem with high morbidity and mortality. Thus, the present study attempted to detect the frequency of carbapenemase producing K. pneumoniae in Dhaka city of Bangladesh and thereby determine the health risk associated with their presence. A total of 647 K. pneumoniae isolates were detected from 2800 patients with urinary tract infection, bacterimia, wound infections and respiratory diseases. Thirty one carbapenem resistant isolates were found to harbor K. pneumoniae carbapenemase (KPC) through modified Hodge test. The KPC positive isolates were then subjected to the study of antibiogram and showed resistance against all the ß-lactam antibiotics along with carbapenems, while they were sensitive against colistin. Additionally, 287 isolates were found to be extended-spectrum ?-lactamases (ESBLs) positive apart from the KPC positive ones. DOI: http://dx.doi.org/10.3329/sjm.v2i1.15210 Stamford Journal of Microbiology, Vol.2(1) 2012: 28-30

Sign in / Sign up

Export Citation Format

Share Document